nach oben

World Journal of Urology

Erschienen in:

01.01.2016 | Topic Paper

Is robotic-assisted radical cystectomy (RARC) with intracorporeal diversion becoming the new gold standard of care?

verfasst von: Hitendra R. H. Patel, Pedro Bargão Santos, Manuel Castanheira de Oliveira, Stig Müller

Erschienen in: World Journal of Urology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Totally intracorporeal robotic-assisted radical cystectomy (RARC) has perceived difficulties compared to open radical cystectomy (ORC). As the technique is increasingly adopted around the world, the benefits of RARC with intra- or extracorporeal urinary diversion or ORC for the patients are still unclear. In this article, we consider the current evidence for this issue.

Methods

We assessed two questions through using expert opinion and the medical literature: (A) Is RARC better than ORC for removing the cancer surgery and outcome? (B) Is RARC better than ORC for the urinary diversion?

Outcomes

(A) RARC is better than ORC for shorter length of stay, blood loss and complication rates. (B) Intracorporeal orthotopic neobladder may have a significant physiological and surgical benefit to the patient recovery.

Conclusions

RARC with total intracorporeal reconstruction has potential benefits to the patient. We recommend that all surgeons document patient-related outcome measures, urodynamics and enhanced recovery protocols for cystectomy patients to help us understand the real improvements within bladder cancer surgery and reconstruction.

Beecken WD, Wolfram M, Engl T, Bentas W, Probst M, Blaheta R, Oertl A, Jonas D, Binder J (2003) Robotic-assisted laparoscopic radical cystectomy and intra-abdominal formation of an orthotopic ileal neobladder. Eur Urol 44(3):337–339CrossRefPubMed

Leow JJ, Reese SW, Jiang W, Lipsitz SR, Bellmunt J, Trinh QD, Chung BI, Kibel AS, Chang SL (2014) Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States. Eur Urol 66(3):569–576. doi:10.1016/j.eururo.2014.01.029 CrossRefPubMed

Novara G, Catto JW, Wilson T, Annerstedt M, Chan K, Murphy DG, Motttrie A, Peabody JO, Skinner EC, Wiklund PN, Guru KA, Yuh B (2015) Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol 67(3):376–401. doi:10.1016/j.eururo.2014.12.007 CrossRefPubMed

Raza SJ, Wilson T, Peabody JO, Wiklund P, Scherr DS, Al-Daghmin A, Dibaj S, Khan MS, Dasgupta P, Mottrie A, Menon M, Yuh B, Richstone L, Saar M, Stoeckle M, Hosseini A, Kaouk J, Mohler JL, Rha KH, Wilding G, Guru KA (2015) Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the international robotic cystectomy consortium. Eur Urol 68(4):721–728. doi:10.1016/j.eururo.2015.04.021 CrossRefPubMed

Patel HR, Cerantola Y, Valerio M, Persson B, Jichlinski P, Ljungqvist O, Hubner M, Kassouf W, Muller S, Baldini G, Carli F, Naesheim T, Ytrebo L, Revhaug A, Lassen K, Knutsen T, Aarsaether E, Wiklund P, Catto JW (2014) Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy? Eur Urol 65(2):263–266. doi:10.1016/j.eururo.2013.10.011 CrossRefPubMed

Zhuang CL, Ye XZ, Zhang XD, Chen BC, Yu Z (2013) Enhanced recovery after surgery programs versus traditional care for colorectal surgery: a meta-analysis of randomized controlled trials. Dis Colon Rectum 56(5):667–678. doi:10.1097/DCR.0b013e3182812842 CrossRefPubMed

Collins JW, Wiklund NP (2014) Totally intracorporeal robot-assisted radical cystectomy: optimizing total outcomes. BJU Int 114(3):326–333. doi:10.1111/bju.12558 PubMed

Froehner M, Brausi MA, Herr HW, Muto G, Studer UE (2009) Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 56(3):443–454. doi:10.1016/j.eururo.2009.05.008 CrossRefPubMed

Cockcroft JO, Berry CB, McGrath JS, Daugherty MO (2015) Anesthesia for major urologic surgery. Anesthesiol Clin 33(1):165–172. doi:10.1016/j.anclin.2014.11.010 CrossRefPubMed

10.

Phong SV, Koh LK (2007) Anaesthesia for robotic-assisted radical prostatectomy: considerations for laparoscopy in the Trendelenburg position. Anaesth Intensive Care 35(2):281–285PubMed

11.

Dutton TJ, Daugherty MO, Mason RG, McGrath JS (2014) Implementation of the Exeter enhanced recovery programme for patients undergoing radical cystectomy. BJU Int 113(5):719–725. doi:10.1111/bju.12533 CrossRefPubMed

12.

Dutton TJ, McGrath JS, Daugherty MO (2014) Use of rectus sheath catheters for pain relief in patients undergoing major pelvic urological surgery. BJU Int 113(2):246–253. doi:10.1111/bju.12316 CrossRefPubMed

13.

Knox ML, El-Galley R, Busby JE (2013) Robotic versus open radical cystectomy: identification of patients who benefit from the robotic approach. J Endourol 27(1):40–44. doi:10.1089/end.2012.0168 CrossRefPubMed

14.

Richards KA, Kader AK, Otto R, Pettus JA, Smith JJ 3rd, Hemal AK (2012) Is robot-assisted radical cystectomy justified in the elderly? A comparison of robotic versus open radical cystectomy for bladder cancer in elderly ≥75 years old. J Endourol 26(10):1301–1306. doi:10.1089/end.2012.0035 CrossRefPubMed

15.

Ost MC, Tan BJ, Lee BR (2005) Urological laparoscopy: basic physiological considerations and immunological consequences. J Urol 174(4 Pt 1):1183–1188CrossRefPubMed

16.

Grande M, Tucci GF, Adorisio O, Barini A, Rulli F, Neri A, Franchi F, Farinon AM (2002) Systemic acute-phase response after laparoscopic and open cholecystectomy. Surg Endosc 16(2):313–316. doi:10.1007/s00464-001-9042-5 CrossRefPubMed

17.

Carter JJ, Whelan RL (2001) The immunologic consequences of laparoscopy in oncology. Surg Oncol Clin N Am 10(3):655–677PubMed

18.

Gkegkes ID, Karydis A, Tyritzis SI, Iavazzo C (2014) Ocular complications in robotic surgery. Int J Med Robot. doi:10.1002/rcs.1632 PubMed

19.

Hong JY, Kim WO, Kil HK (2010) Detection of subclinical CO₂ embolism by transesophageal echocardiography during laparoscopic radical prostatectomy. Urology 75(3):581–584. doi:10.1016/j.urology.2009.04.064 CrossRefPubMed

20.

Junghans T, Bohm B, Grundel K, Schwenk W, Muller JM (1997) Does pneumoperitoneum with different gases, body positions, and intraperitoneal pressures influence renal and hepatic blood flow? Surgery 121(2):206–211CrossRefPubMed

21.

Nguyen NT, Perez RV, Fleming N, Rivers R, Wolfe BM (2002) Effect of prolonged pneumoperitoneum on intraoperative urine output during laparoscopic gastric bypass. J Am Coll Surg 195(4):476–483CrossRefPubMed

22.

Horstmann M, Horton K, Kurz M, Padevit C, John H (2013) Prospective comparison between the AirSeal(R) system valve-less trocar and a standard versaport plus V2 trocar in robotic-assisted radical prostatectomy. J Endourol 27(5):579–582. doi:10.1089/end.2012.0632 CrossRefPubMed

23.

Sanchez-Salas R, Collins JW, Adding C, Oscar L, Abolfazi H, Wiklund NP (2015) PE20 A single centre randomized controlled trial assessing the effect of the Airseal® system on operation times for totally intracorporeal RARC. Eur Urol Suppl 14(5):97. doi:10.1016/S1569-9056(15)30202-5

24.

Johns EJ, Kopp UC, DiBona GF (2011) Neural control of renal function. Compr Physiol 1(2):731–767. doi:10.1002/cphy.c100043 PubMed

25.

Capelouto CC, Saltzman B (1993) The pathophysiology of ureteral obstruction. J Endourol 7(2):93–103CrossRefPubMed

26.

Wilson DR (1980) Pathophysiology of obstructive nephropathy. Kidney Int 18(3):281–292CrossRefPubMed

27.

Tan S, Yu W, Lin Z, Chen Q, Shi J, Dong Y, Duan K, Bai X, Xu L, Li J, Li N (2014) Peritoneal air exposure elicits an intestinal inflammation resulting in postoperative ileus. Mediat Inflamm 2014:924296. doi:10.1155/2014/924296

28.

Ahmed K, Khan SA, Hayn MH, Agarwal PK, Badani KK, Balbay MD, Castle EP, Dasgupta P, Ghavamian R, Guru KA, Hemal AK, Hollenbeck BK, Kibel AS, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi RS, Redorta JP, Rha KH, Richstone L, Saar M, Scherr DS, Siemer S, Stoeckle M, Wallen EM, Weizer AZ, Wiklund P, Wilson T, Woods M, Khan MS (2014) Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the international robotic cystectomy consortium. Eur Urol 65(2):340–347. doi:10.1016/j.eururo.2013.09.042 CrossRefPubMed

29.

Xia L, Wang X, Xu T, Zhang X, Zhu Z, Qin L, Zhang X, Fang C, Zhang M, Zhong S, Shen Z (2015) Robotic versus open radical cystectomy: an updated systematic review and meta-analysis. PLoS ONE 10(3):e0121032. doi:10.1371/journal.pone.0121032 PubMedCentralCrossRefPubMed

30.

Fonseka T, Ahmed K, Froghi S, Khan SA, Dasgupta P, Shamim Khan M (2015) Comparing robotic, laparoscopic and open cystectomy: a systematic review and meta-analysis. Arch Ital Urol Androl 87(1):41–48. doi:10.4081/aiua.2015.1.41 CrossRefPubMed

31.

Varadhan KK, Neal KR, Dejong CH, Fearon KC, Ljungqvist O, Lobo DN (2010) The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials. Clin Nutr 29(4):434–440. doi:10.1016/j.clnu.2010.01.004 CrossRefPubMed

32.

Nygren J, Thacker J, Carli F, Fearon KC, Norderval S, Lobo DN, Ljungqvist O, Soop M, Ramirez J, Enhanced Recovery After Surgery Society fPC, European Society for Clinical N, Metabolism, International Association for Surgical M, Nutrition (2013) Guidelines for perioperative care in elective rectal/pelvic surgery: enhanced recovery after surgery (ERAS((R))) Society recommendations. World J Surg 37(2):285–305. doi:10.1007/s00268-012-1787-6 CrossRefPubMed

33.

Lassen K, Coolsen MM, Slim K, Carli F, de Aguilar-Nascimento JE, Schafer M, Parks RW, Fearon KC, Lobo DN, Demartines N, Braga M, Ljungqvist O, Dejong CH, Enhanced Recovery After Surgery Society fPC, European Society for Clinical N, Metabolism, International Association for Surgical M, Nutrition (2013) Guidelines for perioperative care for pancreaticoduodenectomy: enhanced recovery after surgery (ERAS(R)) Society recommendations. World J Surg 37(2):240–258. doi:10.1007/s00268-012-1771-1 CrossRefPubMed

34.

Gustafsson UO, Scott MJ, Schwenk W, Demartines N, Roulin D, Francis N, McNaught CE, Macfie J, Liberman AS, Soop M, Hill A, Kennedy RH, Lobo DN, Fearon K, Ljungqvist O, Enhanced Recovery After Surgery Society fPC, European Society for Clinical N, Metabolism, International Association for Surgical M, Nutrition (2013) Guidelines for perioperative care in elective colonic surgery: enhanced recovery after surgery (ERAS((R))) Society recommendations. World J Surg 37(2):259–284. doi:10.1007/s00268-012-1772-0 CrossRefPubMed

35.

Mortensen K, Nilsson M, Slim K, Schafer M, Mariette C, Braga M, Carli F, Demartines N, Griffin SM, Lassen K, Enhanced Recovery After Surgery G (2014) Consensus guidelines for enhanced recovery after gastrectomy: enhanced recovery after surgery (ERAS(R)) Society recommendations. Br J Surg 101(10):1209–1229. doi:10.1002/bjs.9582 CrossRefPubMed

36.

Persson B, Carringer M, Andren O, Andersson SO, Carlsson J, Ljungqvist O (2015) Initial experiences with the enhanced recovery after surgery (ERAS) protocol in open radical cystectomy. Scand J Urol 49(4):302–307. doi:10.3109/21681805.2015.1004641 PubMed

37.

Karl A, Buchner A, Becker A, Staehler M, Seitz M, Khoder W, Schneevoigt B, Weninger E, Rittler P, Grimm T, Gratzke C, Stief C (2014) A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study. J Urol 191(2):335–340. doi:10.1016/j.juro.2013.08.019 CrossRefPubMed

38.

Cerantola Y, Valerio M, Persson B, Jichlinski P, Ljungqvist O, Hubner M, Kassouf W, Muller S, Baldini G, Carli F, Naesheimh T, Ytrebo L, Revhaug A, Lassen K, Knutsen T, Aarsether E, Wiklund P, Patel HR (2013) Guidelines for perioperative care after radical cystectomy for bladder cancer: enhanced recovery after surgery (ERAS((R))) society recommendations. Clin Nutr 32(6):879–887. doi:10.1016/j.clnu.2013.09.014 CrossRefPubMed

39.

Nguyen DP, Al Awamlh BAH, Wu X, O’Malley P, Inoyatov IM, Ayangbesan A, Faltas BM, Christos PJ, Scherr DS (2015) Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. Eur Urol 68(3):399–405. doi:10.1016/j.eururo.2015.02.003 PubMedCentralCrossRefPubMed

40.

Yuh B, Wilson T, Bochner B, Chan K, Palou J, Stenzl A, Montorsi F, Thalmann G, Guru K, Catto JW, Wiklund PN, Novara G (2015) Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. Eur Urol 67(3):402–422. doi:10.1016/j.eururo.2014.12.008 CrossRefPubMed

41.

Haber GP, Gill IS (2007) Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years. BJU Int 100(1):137–142. doi:10.1111/j.1464-410X.2007.06865.x CrossRefPubMed

42.

Snow-Lisy DC, Campbell SC, Gill IS, Hernandez AV, Fergany A, Kaouk J, Haber GP (2014) Robotic and laparoscopic radical cystectomy for bladder cancer: long-term oncologic outcomes. Eur Urol 65(1):193–200. doi:10.1016/j.eururo.2013.08.021 CrossRefPubMed

43.

Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC, Feuerstein MA, Rapkin B, Parra RO, Herr HW, Laudone VP (2015) Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol 67(6):1042–1050. doi:10.1016/j.eururo.2014.11.043 CrossRefPubMed

44.

Dutta SC, Chang SC, Coffey CS, Smith JA Jr, Jack G, Cookson MS (2002) Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol 168(1):164–167CrossRefPubMed

45.

Porter MP, Penson DF (2005) Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature. J Urol 173(4):1318–1322. doi:10.1097/01.ju.0000149080.82697.65 CrossRefPubMed

46.

Collins JW, Tyritzis S, Nyberg T, Schumacher M, Laurin O, Khazaeli D, Adding C, Jonsson MN, Hosseini A, Wiklund NP (2013) Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy. Eur Urol 64(4):654–663. doi:10.1016/j.eururo.2013.05.020 CrossRefPubMed

47.

Collins JW, Sooriakumaran P, Sanchez-Salas R, Ahonen R, Nyberg T, Wiklund NP, Hosseini A (2014) Robot-assisted radical cystectomy with intracorporeal neobladder diversion: the Karolinska experience. Indian J Urol 30(3):307–313. doi:10.4103/0970-1591.134251 PubMedCentralCrossRefPubMed

48.

Jonsson MN, Adding LC, Hosseini A, Schumacher MC, Volz D, Nilsson A, Carlsson S, Wiklund NP (2011) Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder. Eur Urol 60(5):1066–1073. doi:10.1016/j.eururo.2011.07.035 CrossRefPubMed

49.

Chang DT, Lawrentschuk N (2015) Orthotopic neobladder reconstruction. Urol Ann 7(1):1–7. doi:10.4103/0974-7796.148553 PubMedCentralCrossRefPubMed

50.

Schwentner C, Sim A, Balbay MD, Todenhofer T, Aufderklamm S, Halalsheh O, Mischinger J, Bottge J, Rausch S, Bier S, Stenzl A, Gakis G, Canda AE (2015) Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedure. World J Surg Oncol 13:3. doi:10.1186/1477-7819-13-3 PubMedCentralCrossRefPubMed

51.

Gore JL, Saigal CS, Hanley JM, Schonlau M, Litwin MS, Urologic Diseases in America P (2006) Variations in reconstruction after radical cystectomy. Cancer 107(4):729–737. doi:10.1002/cncr.22058 PubMedCentralCrossRefPubMed

52.

Tyritzis SI, Hosseini A, Collins J, Nyberg T, Jonsson MN, Laurin O, Khazaeli D, Adding C, Schumacher M, Wiklund NP (2013) Oncologic, functional, and complications outcomes of robot-assisted radical cystectomy with totally intracorporeal neobladder diversion. Eur Urol 64(5):734–741. doi:10.1016/j.eururo.2013.05.050 CrossRefPubMed

53.

Yuh BE, Nazmy M, Ruel NH, Jankowski JT, Menchaca AR, Torrey RR, Linehan JA, Lau CS, Chan KG, Wilson TG (2012) Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy. Eur Urol 62(5):806–813. doi:10.1016/j.eururo.2012.06.007 CrossRefPubMed

54.

Anderson CB, Morgan TM, Kappa S, Moore D, Clark PE, Davis R, Penson DF, Barocas DA, Smith JA Jr, Cookson MS, Chang SS (2013) Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? J Urol 189(2):541–547. doi:10.1016/j.juro.2012.09.034 CrossRefPubMed

55.

Lee RK, Abol-Enein H, Artibani W, Bochner B, Dalbagni G, Daneshmand S, Fradet Y, Hautmann RE, Lee CT, Lerner SP, Pycha A, Sievert KD, Stenzl A, Thalmann G, Shariat SF (2014) Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int 113(1):11–23. doi:10.1111/bju.12121 CrossRefPubMed

56.

Erber B, Schrader M, Miller K, Schostak M, Baumunk D, Lingnau A, Schrader AJ, Jentzmik F (2012) Morbidity and quality of life in bladder cancer patients following cystectomy and urinary diversion: a single-institution comparison of ileal conduit versus orthotopic neobladder. ISRN Urol 2012:342796. doi:10.5402/2012/342796 PubMedCentralPubMed

57.

Ong K, Herdiman O, Johnson L, Lawrentschuk N (2013) Orthotopic bladder substitution (neobladder): part I: indications, patient selection, preoperative education, and counseling. J Wound Ostomy Continence Nurs 40(1):73–82. doi:10.1097/WON.0b013e31827759ea CrossRefPubMed

58.

Hautmann RE, de Petriconi RC, Volkmer BG (2011) 25 years of experience with 1,000 neobladders: long-term complications. J Urol 185(6):2207–2212. doi:10.1016/j.juro.2011.02.006 CrossRefPubMed

59.

Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB (2006) Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367(9518):1241–1246. doi:10.1016/S0140-6736(06)68438-9 CrossRefPubMed

60.

Sloff M, de Vries R, Geutjes P, IntHout J, Ritskes-Hoitinga M, Oosterwijk E, Feitz W (2014) Tissue engineering in animal models for urinary diversion: a systematic review. PLoS ONE 9(6):e98734. doi:10.1371/journal.pone.0098734 PubMedCentralCrossRefPubMed

Titel: Is robotic-assisted radical cystectomy (RARC) with intracorporeal diversion becoming the new gold standard of care?
verfasst von: Hitendra R. H. Patel
Pedro Bargão Santos
Manuel Castanheira de Oliveira
Stig Müller
Publikationsdatum: 01.01.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 1/2016
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-015-1730-1

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Outcomes

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Open radical cystectomy: still the gold standard for muscle invasive bladder cancer

Orthotopic urinary diversion in the elderly

Evolving concepts in muscle-invasive bladder cancer

Involvement of renin–angiotensin–aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury